SNIPR001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SNIPR001, covering 2025-10-14 to 2025-10-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant [Phase 1, Phase 2]